Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-13-003920
Filing Date
2013-03-01
Accepted
2013-03-01 21:14:09
Documents
1
Period of Report
2013-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 8070
  Complete submission text file 0001179110-13-003920.txt   9559
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Issuer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 REDBERRY RIDGE PORTOLA VALLEY CA 94028
Business Address
Swisher Daniel N JR (Reporting) CIK: 0001323113 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51531 | Film No.: 13659756